1. Turkey Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Selcuk Ecza Deposu Ticaret ve Sanayi A.S.

Selcuk Ecza Deposu Ticaret ve Sanayi A.S.

BBIST:SELEC
66.30
TRY
+6.00
(+9.95%)
3.28EPS
63.92P/E
130.22BMarket Cap
Nov 11Next Earn
Selcuk Ecza Deposu Ticaret ve Sanayi A.S.
BIST:SELEC
(Istanbul Exchange)

Recent

price

66.30

P/E

ratio

63.92

div

yld

0.56%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
TRY
7.89
8.17
7.89
8.43
10.28
12.05
13.92
17.21
21.69
28.68
33.86
42.21
137.19
227.19
271.1
276.99
315.36
Revenue per Share
0.3
0.22
0.24
0.25
0.27
0.31
0.39
0.48
0.63
1.12
0.94
1.49
1.02
0.52
4.34
-0.61
3.28
Basic EPS, GAAP
0.11
-0.01
0.01
0.03
0.02
-0.18
0.17
0.07
-0.13
1.2
0.51
0.04
-2.25
2.74
-19.68
10.26
-6.6
Free Cash Flow per Basic Share
0.12
0.06
0.05
0.05
0.06
0.06
0.07
0.08
0.1
0.1
0.17
0.17
1.03
0.52
0.4
0.46
0.37
Dividend per Share
1.79
1.95
2.14
2.32
2.52
2.76
3.07
3.46
3.98
4.98
5.74
7.03
24.48
35.02
49.52
48.26
59.76
Book Value per Share
1.74
1.9
2.08
2.27
2.47
2.7
3.02
3.41
3.93
4.93
5.69
6.98
23.74
33.96
48.03
46.83
58.1
Tangible Book Value per Share
621
621
621
621
621
621
621
621
621
621
621
621
621
621
621
621
621
Basic Weighted Avg Shares
4,902
5,074
4,902
5,238
6,386
7,480
8,643
10,686
13,467
17,809
21,027
26,215
85,197
141,086
168,353
172,011
195,837
Sales/Revenue/Turnover
3.64
2.61
3.05
2.93
2.44
2.46
2.95
3.16
3.18
4.24
3.25
4.29
5.55
4.74
4.21
2.19
4.55
Operating Margin (%)
8
9
11
12
14
17
21
29
40
62
89
82
457
603
816
891
930
Depreciation Expense
184
139
148
152
165
191
244
301
391
695
587
923
636
322
2,695
-380
2,037
Net Income, GAAP
20.31
19.88
20.95
20.31
20.3
20.22
20.14
20.03
22.26
22.09
22.25
25.09
28.25
79.82
35.41
130.83
60.81
Effective Tax Rate (%)
3.75
2.73
3.02
2.91
2.59
2.55
2.82
2.82
2.91
3.9
2.79
3.52
0.75
0.23
1.6
-0.22
1.04
Profit Margin (%)
957
1,027
1,119
1,201
1,239
1,307
1,435
1,593
1,822
2,399
2,770
3,497
9,363
13,570
19,467
18,959
24,726
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
33
22
12
29
618
80
125
98
LT Debt
1,112
1,213
1,326
1,440
1,563
1,711
1,905
2,150
2,470
3,091
3,568
4,367
15,199
21,746
30,753
29,973
37,113
Total Equity
13.35
9.65
8.15
7.11
9.1
10.89
13.3
15.55
19.01
22.34
14.99
19.96
34.59
6.86
12.08
-1.85
8.27
Return on Invested Capital (%)
29.67
15.96
9.06
9.37
10.01
11.33
13.29
15.34
19.69
23.78
18.27
22.95
7.38
2.7
14.32
-2.05
6.69
Return on Capital (%)
17.41
11.92
11.67
11.02
11.02
11.65
13.47
14.85
16.94
24.99
17.63
23.26
6.5
1.74
10.27
-1.25
6.37
Return on Common Equity (%)

Capital Structure

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
670
5,974
6,049
LT Borrowings
- -
- -
- -
LT Finance Leases
125
110
98
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
621
621
621
Market Capitalization
54,027
49,991
130,224

Working Capital

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
68,849
84,548
87,684
Cash, Cash Equivalents & STI
5,725
11,341
11,968
Accounts Receivable, Net
42,564
49,913
52,059
Inventories
16,683
19,040
19,069
Total Current Liabilities
49,889
61,900
62,958
Payables & Accruals
- -
- -
- -
ST Debt
670
5,974
6,049
Deferred Revenue
- -
- -
- -

Growth Rates

TRY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
43.21%
70.49%
-2.54%
Free Cash Flow
-856.29%
-1,388.07%
-152.12%
Net Income, GAAP
74.22%
119.78%
-114.09%
Sales/Revenue/Turnover
45.23%
67.35%
2.17%
Total Cash Common Dividend
- -
89.56%
16.06%

Quarterly Revenue

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
38,464
33,752
39,543
38,846
168,353
2025
49,061
47,699
42,205
48,267
172,011
2026
51,926
53,440
- -
- -
- -

Quarterly Earnings Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.55
0.29
0.44
2.28
4.34
2025
- -
-0.68
-0.36
0.3
-0.61
2026
2.48
0.86
- -
- -
- -

Quarterly Dividends Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.03
0.02
0.4
2025
- -
- -
-0.1
0.02
0.46
2026
- -
0.45
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Cencora, Inc. (NYSE:COR)
Business
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. (SELEC.IS) operates as Turkey's leading pharmaceutical wholesaler and distributor, holding approximately 40% market share in the sector; it organizes distribution channels between drug manufacturers, hospitals, and over 27,000 pharmacies nationwide. The company distributes a comprehensive range of pharmaceutical products, cosmetics, personal care items, infant food, vitamins, medical supplies, and similar healthcare goods through an extensive network of 26 central branches and 86 regional depots, supported by nearly 6,000 employees and a fleet of around 2,300 vehicles. Founded in 1958 and headquartered in Istanbul, Turkey, it functions as a subsidiary of Selçuk Ecza Holding A.S., with key subsidiaries including As Ecza Deposu Ticaret A.S. and Selçuk Ecza Deposu Dış Ticaret A.S., primarily serving the domestic market while maintaining operations aligned with Turkey's regulated pharmaceutical ecosystem. In recent developments, Selçuk Ecza Holding increased its ownership in the company to 82.42% through the purchase of an additional 5.1% of publicly traded shares; the company reported consolidated 2024 sales of TRY 128.6 billion, gross profit of TRY 13.0 billion, and net profit of TRY 2.1 billion, reflecting a 539% year-over-year net profit surge amid inflation-adjusted financials; operational expansions include growth to 112 total warehouses from 110 in 2023, with sustained market leadership since 2014 and credit ratings of AA (tr) long-term national stable from October 2024.